Cartesian Therapeutics, Inc. Common Stock
$8.03
$0.17 (+2.16%)
$7.66Day Range$8.26
Key Statistics
Market Cap
$242.95M
Shares Outstanding
30.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 22, 2016
Round Lot
100
Locale
US
Trading Data
Day Open
$7.88
Day High
$8.26
Day Low
$7.66
Volume
211.7K
VWAP
$7.95
Prev Close
$7.86
Transactions
--
Acc. Volume
--
About Cartesian Therapeutics, Inc. Common Stock
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
PHARMACEUTICAL PREPARATIONSSIC 283475 employees7495 NEW HORIZON WAY, FREDERICK, MD, 21703301-348-8698IPO Jun 22, 2016US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001453687
- Composite FIGI
- BBG001J19Q25
- Share Class FIGI
- BBG001V0FQQ0
- Ticker Root
- RNAC
- SIC Code
- 2834
About Cartesian Therapeutics, Inc. Common Stock (RNAC) Stock
Cartesian Therapeutics, Inc. Common Stock (RNAC) closed the 2026-09-18 session at $8.03, up 2.16% versus the previous close (+0.17). The stock opened at $7.88 and traded between $7.66 and $8.26 during that session. Session trading volume was 212K shares. The volume-weighted average price (VWAP) is $7.95.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Cartesian Therapeutics, Inc. Common Stock has a market capitalization of $243.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. RNAC is listed on the XNAS exchange. The company employs approximately 75 people. Cartesian Therapeutics, Inc. Common Stock is headquartered in FREDERICK, MD. The recorded listing date is 2016-06-22.
On this page you can find market RNAC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.